A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: Efficacy, quality-of-life and toxicity
Journal article published in 2005 by
Borner Mm,
D. Dietrich,
J. Bernhard,
M. M. Borner,
R. Popescu,
M. Wernli,
P. Saletti,
D. Rauch,
R. Herrmann,
D. Koeberle,
H. Honegger,
P. Brauchli,
D. Lanz 
,
Roth Ad,
A. D. Roth
and other authors.
,
Roth Ad,
A. D. Roth
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 